Search Within

CTCR Scholars

  1. "Christine Iacobuzio-Donahue"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (16)
  3. Editorial (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (40)
  2. Center for Pancreatic Cancer Research (40)
  3. Department of Pathology and Laboratory Medicine (40)
  4. GSK Faculty (40)
  5. Human Oncology and Pathogenesis Program (40)
  6. MSK Grad Students (36)

More Groups

People
  1. Christine Iacobuzio-Donahue (40)
  2. Vinod Balachandran (17)
  3. Eileen O'Reilly (15)
  4. Kevin Soares (15)
  5. Wungki Park (15)
  6. Alice Wei (11)

More People

Years
  1. 2024 (5)
  2. 2023 (8)
  3. 2022 (9)
  4. 2021 (6)
  5. 2020 (10)
  6. 2019 (2)
Publications
  1. Journal of Clinical Oncology (9)
  2. Cancer Research (8)
  3. Clinical Cancer Research (5)
  4. Annals of Surgical Oncology (3)
  5. Blood (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. American Society of Clinical Oncology (10)
  3. Nature Publishing Group (3)
  4. Springer (3)
  5. American Society of Hematology (2)
  6. Oxford University Press (2)

More Publishers

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Patient-derived biliary tract cancer organoid biobank: Is personalized medicine utilizing organoids feasible for patients with cholangiocarcinoma?
    Meeting Abstract

    Nasar, N.; McIntyre, S. M. H.; Kalvin, H. L.; Gonen, M.; Lecomte, N.; Karnoub, E.; Hong, J.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Concordance in oncogenic alterations between the primary tumor and advanced disease: Insights into the heterogeneity of intrahepatic cholangiocarcinoma
    Journal Article

    McIntyre, S. M.; Preston, W. A.; Walch, H.; Sharib, J.; Kundra, R.; Sigel, C.; Lidsky, M. E.; Allen, P. J.; Morse, M. A.; Chen, W.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • A novel approach to quantify heterogeneity of intrahepatic cholangiocarcinoma: The hidden-genome classifier
    Journal Article

    Song, Y.; Boerner, T.; Drill, E.; Shin, P.; Kumar, S.; Sigel, C.; Cercek, A.; Kemeny, N.; Abou-Alfa, G.; Iacobuzio-Donahue, C.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Patient-derived biliary tract cancer organoid biobank: Is personalized medicine utilizing organoids feasible for patients with cholangiocarcinoma?
    Meeting Abstract

    Nasar, N.; McIntyre, S. M.; Kalvin, H. L.; Gonen, M.; Lecomte, N.; Karnoub, E. R.; Hong, J.; Soares, K. C.; Balachandran, V. P.; Drebin, J.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Subclonal somatic copy-number alterations emerge and dominate in recurrent osteosarcoma
    Journal Article

    Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Arnold, B.; Levine, M. F.; Gundem, G.; Arango Ossa, J. E.; Glodzik, D.; Rodríguez-Sanchez, M. I.; Bouvier, N.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing
    Meeting Abstract

    McIntyre, S. M.; Preston, W.; Walch, H.; Sigel, C.; Sharib, J.; Chen, W.; Lidsky, M. E.; Kundra, R.; Cercek, A.; Harding, J. J.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Genetic heterogeneity of intrahepatic cholangiocarcinoma: Implications for outcome
    Meeting Abstract

    Song, Y.; Boerner, T.; Drill, E.; Shin, P.; Cercek, A.; Kemeny, N. E.; Abou-Alfa, G. K.; Iacobuzio-Donahue, C.; Schultz, N.; Walch, H.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
    Journal Article

    DeWolf, S.; Elhanati, Y.; Nichols, K.; Waters, N. R.; Nguyen, C. L.; Slingerland, J. B.; Rodriguez, N.; Lyudovyk, O.; Giardina, P. A.; Kousa, A. I.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save